S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 134

Issue Date	Title / Author(s) / Citation	File
1982-06	혈액투석을 이용한 메타놀 중독환자 치료일례 허대석; 오하영; 김성권; 이정상 Seoul J Med, Vol.23 No.2, pp. 279-283	view file
1998-12	암환자 응급진료의 현황 및 문제점 허대석; 윤영호; 정주영; 김홍수; 김성혜; 신상도; 김중의; 오은경; 유철규; 방영주; 김노경 한국호스피스완화의료학회지, Vol.1 No.1, pp.14-22
2002-03	항문암의 치료성적: 비수술적방법과 수술적방법의 결과 비교 지의규; 하성환; 박재갑; 방영주; 허대석; 김노경 Radiation oncology journal, Vol.20 No.1, pp.62-67
2004-06	Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog Journal of Immunology, Vol.172 No.12, pp.7335-7340	DOI
2006-04	EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care unit Park, Sang Min; Park, Myung Hee; Won, Joo Hee; Lee, Kyoung Ok; Choe, Wha Sook; Heo, Dae Seog; Kim, Si-Young; Lee, Kyung Sik; Yun, Young Ho SUPPORTIVE CARE IN CANCER Vol.14 No.4, pp. 329-333	DOI
2006-09	Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL) Yun, Young Ho; Kim, Soo-Hyun; Lee, Kyoung-Min; Park, Sang Min; Lee, Chang Geol; Choi, Youn Seon; Lee, Won Sup; Kim, Si-Young; Heo, Dae Seog EUROPEAN JOURNAL OF CANCER Vol.42 No.14, pp. 2310-2317	DOI
2007-10	Palliative chemotherapy for pulmonary pleomorphic carcinoma Bae, Hyun-Mi; Min, Hye Sook; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong-Seok; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.58 No.1, pp.112-115	DOI
2007-12	Chemotherapy use and associated factors among cancer patients near the end of life. Yun, Young Ho; Kwak, Miyoung; Park, Sang Min; Kim, Samyong; Choi, Jong Soo; Lim, Ho-Yeong; Lee, Chang Geol; Choi, Youn Seon; Hong, Young Seon; Kim, Si-Young; Heo, Dae Seog ONCOLOGY Vol.72 No.3, pp. 164-171	DOI
2007-12	Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Kim, D. -W.; Kim, S. -Y.; Kim, H. -K.; Kim, S. -W.; Shin, S. W.; Kim, J. S.; Park, K.; Lee, M. Y.; Heo, D. S. Annals of Oncology, Vol.18 No.12, pp.2009-2014	DOI
2008-02	Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma Song, E. -K.; Kim, S. -Y.; Kim, T. M.; Lee, K. -W.; Yun, T.; Na, I. -I.; Shin, H.; Lee, S. H.; Kim, D. W.; Khwarg, S. I.; Heo, D. S. Annals of Oncology, Vol.19 No.2, pp.242-246	DOI
2008-03	Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer Cho, Yo-Han; Lee, Se Hoon; Kim, Dong-Wan; Wu, Hong-Gyun; Hah, J. Hun; Rhee, Chae-Seo; Sung, Myung-Whun; Kim, Kwang Hyun; Heo, Dae Soeg Head and Neck, Vol.30 No.3, pp.346-350	DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-12	Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deock; Yi, Hyeon Gyu; Kim, Yu Jung; Lee, Se-Hoon; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.62 No.3, pp.381-384	DOI
2009-05	Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis Han, Jung Ho; Park, Chul-Kee; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Chemotherapy, Vol.55 No.3, pp.145-154	view file DOI
2009-08	Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin Park, Chul-Kee; Park, Sung-Hye; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Neuropathology, Vol.29 No.4, pp.443-449	DOI
2009-08	Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Koh, Y.; Kim, T. M.; Jeon, Y. K.; Kwon, T. -K.; Hah, J. H.; Lee, S. -H.; Kim, D. -W.; Wu, H. -G.; Rhee, C. -S.; Sung, M. -W.; Kim, C. W.; Kim, K. H.; Heo, D. S. Annals of Oncology, Vol.20 No.8, pp.1414-1419	DOI
2009-08	Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer Kim, Hee Jun; Kim, Yu Jung; Seo, Myung-Deok; Yi, Hyeon Gyu; Lee, Se-Hoon; Lee, Sang-Min; Kim, Dong-Wan; Yang, Seok-Chul; Lee, Choon-Taek; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog Lung Cancer, Vol.65 No.2, pp.242-246	DOI
2009-10	Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma Kim, W. Y.; Jeon, Y. K.; Kim, T. M.; Kim, J. E.; Kim, Y. A.; Lee, S. -H.; Kim, D. -W.; Heo, D. S.; Kim, C. -W. Annals of Oncology, Vol.20 No.10, pp.1688-1696	DOI
2009-12	Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy Park, Chul-Kee; Lee, Se-Hoon; Han, Jung Ho; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won BMC Cancer, Vol.9, p. 450	view file DOI
2010-05	First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors Kim, Tae Min; Kim, Ki Hwan; Lee, Min Joung; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Kim, Il Han; Khwarg, Sang In; Heo, Dae Seog Cancer Science, Vol.101 No.5, pp.1199-1203	view file DOI
2010-06	Impact of caregivers' unmet needs for supportive care on quality of terminal cancer care delivered and caregiver's workforce performance Park, Sang Min; Kim, Young Jin; Kim, Samyong; Choi, Jong Soo; Lim, Ho-Yeong; Choi, Youn Seon; Hong, Young Seon; Kim, Si-Young; Heo, Dae Seog; Kang, Ki Moon; Jeong, Hyun Sik; Lee, Chang Geol; Moon, Do Ho; Choi, Jin-Young; Kong, In Sik; Yun, Young Ho SUPPORTIVE CARE IN CANCER Vol.18 No.6, pp. 699-706	DOI
2010-06	Definitive Radiotherapy With or Without Chemotherapy for T3-4N0 Squamous Cell Carcinoma of the Maxillary Sinus and Nasal Cavity Jang, Na Young; Wu, Hong-Gyun; Park, Charn Il; Heo, Dae-Seog; Kim, Dong-Wan; Lee, Se-Hoon; Rhee, Chae-Seo Japanese Journal of Clinical Oncology, Vol.40 No.6, pp.542-548	DOI
2011-01	A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinonna harboring EGFR mutations Kim, Dong-Wan; Lee, Se-Hoon; Lee, Jong Seok; Lee, Myung Ah; Kang, Jin Hyoung; Kim, Si Young; Shin, Sang Won; Kim, Hoon-Kyo; Heo, Dae Seog Lung Cancer, Vol.71 No.1, pp.65-69	DOI
2011-02	Molecular marker analysis of effectiveness in patients with stage II/III breast cancer treated with paclitaxel/gemcitabine-based neoadjuvant chemotherapy 이근석	link
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2011-08	Clinical dissection of multicentric Castleman disease Shin, Dong-Yeop; Jeon, Yoon Kyung; Hong, Yong-Sang; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Inho; Yoon, Sung-Soo; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook Leukemia and Lymphoma, Vol.52 No.8, pp.1517-1522	DOI
2011-11	Clinical significance of tumor-infiltrating FOXP3+T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma Kim, Ki Hwan; Kim, Tae Min; Go, Heounjeong; Kim, Wook Youn; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Khwarg, Sang In; Kim, Chul-Woo; Heo, Dae Seog Cancer Science, Vol.102 No.11, pp.1972-1976	view file DOI
2012-02	인간 대장암 세포주에 대한 bortezomib의 억제 효능의 기전에 관한 연구 홍용상	link
2012-02	자연살해세포 백혈병-림프종 세포주에서 gemcitabine 의 항종양 효능 김태민	link
2012-02	Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer Sim, Sung Hoon; Ahn, Yong-Oon; Yoon, Jieun; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Cancer Science, Vol.103 No.2, pp.155-160	view file DOI
2012-08	Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Park, Heae Surng; Lee, June Koo; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.288-292	DOI
2012-08	EGFR mutations as a predictive marker of cytotoxic chemotherapy Park, Jin Hyun; Lee, Se-Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.433-437	DOI
2012-09	Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis Bae, Hyun-Mi; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Wu, Hong Gyun; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.3, pp.572-577	DOI
2012-12	Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer Koo, Tae Ryool; Wu, Hong-Gyun; Hah, J. Hun; Sung, Myung-Whun; Kim, Kwang-Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae-Seog; Park, Charn Il Cancer Research and Treatment, Vol.44 No.4, pp.227-234	view file DOI
2012-12	Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak Jae; Kim, Dong-Wan; Lee, Se-Hoon; Kim, Tae Min; Kim, Young Whan; Heo, Dae Seog Cancer Research and Treatment, Vol.44 No.4, pp.242-250	view file DOI
2013-01	Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study Lee, June Koo; Keam, Bhumsuk; An, Ah Reum; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Supportive Care in Cancer, Vol.21 No.1, pp.183-190	DOI
2013-02	Comparative analysis of overall survival of patient with non-small cell lung cancer harboring anaplastic lymphoma kinase fusion 이준구	view file
2013-03	Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma Kim, Tae Min; Paeng, Jin Chul; Chun, In Kook; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Dong Soo; Kim, Chul Woo; Chung, June-Key; Kim, Il Han; Heo, Dae Seog Cancer, Vol.119 No.6, pp.1195-1202	DOI
2013-03	Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak jae; Park, Charn Il; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Radiation Oncology Journal, Vol.31 No.1, pp.18-24	view file DOI
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-07	Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy Lim, Yoojoo; Keam, Bhumsuk; Koh, Youngil; Kim, Tae Min; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog; Kim, Kwang Hyun Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.116 No.1, pp.55-60	DOI
2013-08	Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Lee, J. K.; Shin, J. -Y.; Kim, S.; Lee, S.; Park, C.; Kim, J. -Y.; Koh, Y.; Keam, B.; Min, H. S.; Kim, T. M.; Jeon, Y. -K.; Kim, D. -W.; Chung, D. H.; Heo, D. S.; Lee, S. -H.; Kim, J. -I. Annals of Oncology, Vol.24 No.8, pp.2080-2087	DOI
2013-08	Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non-Small-Cell Lung Cancer Lee, Eunyoung; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.8, pp.1069-1074	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2014-03	Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer Go, Se-Il; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Hak Jae; Wu, Hong-Gyun; Chung, Doo Hyun; Heo, Dae Seog Clinical Lung Cancer, Vol.15 No.2, pp.E1-E6	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2014-06	Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer Lee, Yun-Gyoo; Kim, Inho; Lee, Eunyoung; Bang, Soo-Mee; Kang, Chang Hyun; Kim, Young Tae; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Young Whan; Kim, Tae Min; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thrombosis and Haemostasis, Vol.111 No.6, pp.1112-1120	view file DOI
2014-08	In vitro anticancer activity of phosphatidylinositol 3-kinase alpha selective inhibitor BYL719 in head and neck cancer 김범석	view file
2014-08	The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: A retrospective cohort study Shin, Dong-Yeop; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Young Tae; Heo, Dae Seog Lung Cancer, Vol.85 No.2, pp.320-325	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2014-10	Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non-Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib A Phase I/II Trial Park, Keunchil; Cho, Byoung C.; Kim, Dong-Wan; Ahn, Myung-Ju; Lee, Sang-Yoon; Gernhardt, Diana; Taylor, Ian; Campbell, Alicyn K.; Zhang, Hui; Giri, Nagdeep; Letrent, Stephen P.; O'Connell, Joseph; Heo, Dae S. Journal of Thoracic Oncology, Vol.9 No.10, pp.1523-1531	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2014-12	Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score Lee, Dae-Won; Shin, Dong-Yeop; Kim, Jin Wook; Keam, Bhumsuk; Kim, Tae Min; Kim, Hak Jae; Kim, Dong-Wan; Wu, Hong-Gyun; Paek, Sun Ha; Kim, Young Whan; Heo, Dae Seog; Kim, Dong Gyu; Lee, Se-Hoon Lung Cancer, Vol.86 No.3, pp.363-368	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2015-01	In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Anticancer Research, Vol.35 No.1, pp.175-182
2015-02	상피세포성장인자수용체 돌연변이 폐암에서 insulin-like growth factor-1 발현의 의의 나임일	view file

1 2 3